Facebook
Twitter
LinkedIn
Forward
Mind Over Migraines: Disease Burden, Innovative Therapies, and Managed Care Trends in Treating Migraines
Overview
Pricing: Free for Members and Non-Members
Course Description
Migraine is a complex, neurobiological disorder characterized by recurrent and often debilitating headaches, typically affecting one side of the head, accompanied by symptoms such as nausea, vomiting, and sensitivity to light and sound. New therapies, such as monoclonal antibodies acting on CGRP or its receptors, offer promising improvements in migraine prevention and treatment, leading to important considerations for managed care organizations on integrating these advancements into practice and structuring pharmacy benefit design accordingly.
This session will provide insights into the multifaceted nature and accompanying health conditions of migraines, their burden on an individual’s quality of life, and effective treatment methodologies that can be integrated into formulary coverage policies and design. Additionally, this session will review current utilization patterns, identify shortcomings in existing benefit structures, and discover methods to evaluate valuable coverage strategies to improve migraine health outcomes for a diverse population.
Target Audience
Pharmacists who practice in managed care settings.
Learning Objectives
At the completion of this activity, participants should be able to:
- Examine the migraine disease burden to evaluate the significance of treatment outcomes.
- Explain the role of calcitonin gene-related peptide (CGRP) receptor antagonists in the acute and preventative management of migraine.
- Identify emerging evidence supporting innovative pipeline migraine treatment modalities.
- Discuss managed care strategies to ensure timely and equitable access to essential migraine therapies.
Commercial Support
This activity is supported by an independent medical education grant from Pfizer, Inc.
Faculty
Laura R. Bobolts, PharmD, BCOP
SVP, Clinical Strategy and Growth
OncoHealth
Pompano Beach, FL
Melissa Pozotrigo, PharmD, BCOP
Senior Clinical Pharmacist
Oncohealth
Atlanta, GA
Susan Wojcicki, PharmD
Clinical Pharmacy Lead
Humana Pharmacy Solutions Clinical and Specialty Strategies
Louisville, KY
Faculty/Reviewer/Planner | Reported Relevant Financial Relationships |
Susan Wojcicki, PharmD, BCOP Faculty | Disclosed no relevant financial relationships. |
Melissa Pozotrigo, PharmD, BCOP Faculty | Disclosed no relevant financial relationships. |
Laura R. Bobolts, PharmD, BCOP Faculty | Steering Committee Member: Pfizer |
Amy Lugo, PharmD, BCPS, BC-ADM Reviewer | Disclosed no relevant financial relationships. |
Brittany V. Henry, PharmD, MBA Planner | Disclosed no relevant financial relationships. |
Accreditation
The Academy of Managed Care Pharmacy (AMCP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
ACPE UAN: 0023-0000-25-021-H01-P • Activity Type: Knowledge-Based
Contact Hours: 1.25
Release Date: April 11, 2025 • Expiration Date: December 31, 2026
Activity Fee: Free for Members and Non-Members
Participants should claim continuing pharmacy education (CPE) credit for this home study activity only if they have not claimed credit for the live activity presented at Nexus 2024. CPE credit will be processed through the AMCP Learn portal and reported directly to CPE Monitor. Please allow 72 hours for processing and posting in your NABP account.
To receive credit for an online activity you must:
- Review the full content of the activity.
- Successfully complete the post-test (required to pass with a score of 70% or higher, it may be taken a maximum of three times).
- Complete a specific activity evaluation.
Available Credit
- 1.25 ACPE
The Academy of Managed Care Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.